SKU shown: BCDA (BioClean-C™ Chemotherapy Protective Apron).
Why aprons matter in cleanrooms (and in chemo handling)
In controlled environments, garments serve two jobs: protect the process from the operator and protect the operator from the task. A chemotherapy protective apron is typically used as an outer, front-of-body layer when handling cytotoxic drugs or related chemicals.
BioClean-C™ Apron BCDA is positioned as a lightweight, low-linting CleanTough™ apron tested to the ASTM F739-12 permeation method against a range of chemotherapy drugs (manufacturer-published results). Use it as part of a documented gowning program and a contamination control strategy.
What this apron is used for
- Chemotherapy (cytotoxic) drug preparation, handling, administering, and spill-risk tasks where an apron layer is specified.
- Front torso protection over compatible cleanroom garments in laboratories, controlled environments, and manufacturing support areas.
- Compounding and mixing tasks where splash/contact risk exists and SOP calls for a disposable protective apron.
- Contamination-control programs requiring low-linting apparel as part of an operations control program.
Why customers consider this product
- Chemo permeation method basis: manufacturer reports ASTM F739-12 MBT for a range of chemotherapy drugs.
- Low-linting / controlled-environment fit: CleanTough™ material and published Helmke Drum result support controlled use decisions.
- Practical, repeatable donning: adjustable neck fastening and rear tie tapes simplify consistent wear over approved base garments.
- Documentation availability: PDS, IFU, and EU/UK Declarations of Conformity support qualification and receiving review.
- Case-pack discipline: inner/outer bag packaging supports staged opening and controlled introduction practices.
Materials, composition, and construction
The BCDA apron is manufactured from CleanTough™ material and is described by the manufacturer as lightweight and low-linting. Construction includes an adjustable neck fastening with tie fastening at the waist.
Label/IFU documentation identifies apron composition as a polypropylene/polyethylene blend with an adhesive component. Always treat the IFU and garment label as the controlling reference for your receiving/qualification file.
Specifications in context
| Attribute |
BCDA |
| Manufacturer / brand | Ansell BioClean |
| Sterility | Non-sterile |
| Material | CleanTough™ (lightweight, low-linting) |
| Construction | Adjustable neck fastening; tie fastening at waist |
| Available sizes | S, M, L |
| Particle shedding | Helmke Drum Test: ≥ 0.5µm < 1700 counts/min |
| Chemo permeation test method | ASTM F739-12 (MBT; breakthrough at 0.1 µg/cm2/min) |
| Published chemo drug MBT (minutes) | Cisplatin >480; Carmustine >240; Cyclophosphamide >480; Doxorubicin HCl >480; 5-Fluorouracil >480; Methotrexate >480; Etoposide >480; Paclitaxel >480; Thiotepa >456 |
| Packaging overview | 1 piece per sealed inner PE bag; 1 inner bag per sealed outer PE bag; 50 outer bags per lined carton |
| Shelf life | Five (5) years from date of manufacture |
| Storage | Keep away from direct sunlight; store dry in original packaging; keep away from ozone sources |
| Country of origin | China |
Performance and cleanliness considerations
Cleanroom reality check: garments fail when technique fails
- Low-linting helps, but handling dominates: grabbing the front panel or brushing against non-controlled surfaces can negate material advantages.
- Helmke Drum results are comparative indicators: they help evaluate shedding under test conditions, but your airflow, movement, and tasks determine actual contamination contribution.
- Chemo permeation results require context: drug type, concentration, temperature, exposure duration, and seam/closure design affect real-world protection.
Packaging, traceability, and documentation control
BCDA packaging uses a sealed inner PE bag inside a sealed outer PE bag, with 50 outer bags per lined carton. For controlled environments, staged opening supports cleaner introduction practices.
Documentation for qualification commonly includes the PDS, IFU, and Declarations of Conformity. For lot-level documentation, use the manufacturer certificate search process with product style and lot/batch identifiers from case labels.
Proper gowning (donning) to minimize contamination: ISO first, then EU Annex 1
ISO-based approach (operations control and gowning discipline)
- Stage the package correctly: open the shipper/outer packaging in the lower-grade area; transfer only the clean bag layer forward per SOP.
- Hand hygiene and base gown first: complete hand hygiene and don required base garments before adding the apron layer.
- Handle by ties/edges, not the front panel: keep the main front surface facing away from your hands.
- Secure neck, then waist: set the adjustable neck fastening first, then tie at the waist for full front torso coverage.
- Final contamination-control check: confirm coverage, secure ties, and that the apron does not contact the floor or non-controlled surfaces.
EU GMP Annex 1 context
EU GMP Annex 1 emphasizes contamination prevention through a documented Contamination Control Strategy. If your process is governed by Annex 1 or aseptic processing controls, evaluate whether a sterile apron variant is required by SOP, and ensure aseptic donning technique is trained and enforced.
Common failure modes
- Touching the front panel during donning: handle by ties/edges; treat the front as a critical surface.
- Dragging or brushing the apron against benches: maintain clearance and controlled movements in gowning areas.
- Re-tying with contaminated gloves: finalize fit before task initiation; replace apron if adjustment is required mid-task.
- Assuming permeation data equals full-system protection: seams, closures, glove interfaces, and task conditions control real risk.
- Overuse beyond intended duration: replace after spills/splashes or damage, and follow disposal rules in your hazardous waste program.
Closest alternatives
- Aprons with sleeves: higher arm coverage where splash/contact risk extends beyond the torso (see BCAS / S-BCAS options).
- Sterile variants: required when SOP mandates sterile packaging for entry into aseptic or sterile processing areas.
- Other chemo apron programs: evaluate published drug lists, MBT reporting, seam construction, and certificate access procedures.
Critical environment fit
BCDA is typically selected where a non-sterile, low-linting chemotherapy protective apron is appropriate as an outer layer over a validated base gowning system.
SOSCleanroom note about SOP's
The Technical Vault is written to help customers make informed contamination-control decisions and improve day-to-day handling technique. It is not your facility's SOP, batch record, or validation protocol.
If you adapt any technique guidance from this entry, treat it as a starting template. Your team should review and approve the final method, then qualify it for your specific process and hazards.
Source basis (manufacturer-first)
SOSCleanroom is the source for this Technical Vault entry.
Briefed and approved by the SOSCleanroom (SOS) staff.
If you have any questions please email us at Sales@SOSsupply.com
If you need additional information please try our SOSCleanroom specific AI ChatBot which draws from our extensive cleanroom specific libraries.
Last reviewed: May 1, 2026
© 2026 SOSCleanroom
